0001213900-24-069038.txt : 20240814
0001213900-24-069038.hdr.sgml : 20240814
20240814161520
ACCESSION NUMBER: 0001213900-24-069038
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240812
FILED AS OF DATE: 20240814
DATE AS OF CHANGE: 20240814
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Townsend John
CENTRAL INDEX KEY: 0001511906
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40582
FILM NUMBER: 241208015
MAIL ADDRESS:
STREET 1: 15150 AVENUE OF SCIENCE
STREET 2: SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92128
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Unicycive Therapeutics, Inc.
CENTRAL INDEX KEY: 0001766140
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 813638692
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4300 EL CAMINO REAL, SUITE 210
CITY: LOS ALTOS
STATE: CA
ZIP: 94022
BUSINESS PHONE: 650-384-0642
MAIL ADDRESS:
STREET 1: 4300 EL CAMINO REAL, SUITE 210
CITY: LOS ALTOS
STATE: CA
ZIP: 94022
4
1
ownership.xml
X0508
4
2024-08-12
0
0001766140
Unicycive Therapeutics, Inc.
UNCY
0001511906
Townsend John
C/O UNICYCIVE THERAPEUTICS
LOS ALTOS
CA
94022
0
1
0
0
Chief Financial Officer
0
Stock Options
0.34
2024-08-12
4
A
0
40256
0
A
2034-08-12
Common Stock
40256
915565
D
10,064 of the stock options vest on August 12, 2025 and 1/36th of the remaining options vest at the end of each successive month thereafter.
/s/ John Townsend
2024-08-14